FEMSelect

Surgical Devices · Newark, DE · Founded 2012 · Privately Held (backing)

Developer of medical devices designed to treat pelvic organ prolapse disease in women. FEMSelect is based in Newark, DE and was founded in 2012. It was valued at $17 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $12.2 million across 1 recorded round; the latest was an accelerator round in Jan 2018.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$12.2M
Last round
Accelerator/Incubator
Jan 2018

Who backs FEMSelect?

21 investors
InvestorType
Springboard EnterprisesOther
Keiretsu ForumOther
Innovation AuthorityOther
New York AngelsAngel
Robin Hood VenturesAngel
Nordwand CapitalFamily office
Avea Ventures—
Backswing Ventures—
CPOINT Capital—
ForMED Ventures—
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

FEMSelect investors

21 investors are on record for FEMSelect, including Springboard Enterprises, Keiretsu Forum, Innovation Authority and New York Angels.

Free account
More of FEMSelect with a free account
  • ·The complete investor list: 21 names
  • ·Watch FEMSelect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like FEMSelect in surgical devices. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View